PEStore

Venture Capital

Theodorus Investment Funds

Theodorus Investment Funds backs early-stage and high-growth companies, typically pre-profit, from Brussels, Belgium. It states a focus on healthcare & life sciences.

Disclosed holdings29
Earliest stated investment2015
HeadquartersBrussels, Belgium
Stated fund size€70 Million

Stated investment criteria

What Theodorus Investment Funds says it buys

Read from Theodorus Investment Funds’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Founded20122
OfficesMontreal2
People listed on its team page101

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Theodorus Investment Funds to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies Theodorus Investment Funds lists on its own website. 4 carry a stated investment year. 2 have a recorded transaction against them in the deal archive.

CompanyInvestedYears heldRecorded transaction
Bone Therapeutics201511
Euro Heat Pipes20179
Ogeda20179$563m 2017
MaSTherCell20206$315m 2020
A Ulab
Acarup
Amia Systems
Antigon
Arogga
Calyos Tm
ChromaCure
Cluepoints
Delphigenetics
EPICS Therapeutics
Ehp
Endotools
Gogustaf
I Tech Incubator
Icentia
Inhatarget
Kabandy
Kaspard
Moonshothealth
Novasep
Pharmafluidics
Seederfund
Virteo
X4c
Youknowwatt

Compiled from Theodorus Investment Funds’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Theodorus Investment Funds?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.